BRAIN Biotech AG financial highlights
| in € million | 2021/22 | 2020/21 | 2019/20 |
|---|---|---|---|
| Consolidated income statement data: | |||
| Revenue | 49.5 | 38.4 | 38.2 |
| Total operating performance | 53.1 | 40.7 | 39.2 |
| EBITDA | –1.3 | –2.5 | –3.9 |
| Adjusted EBITDA | –0.1 | –2.1 | –2.0 |
| Net loss for the reporting period | –6.3 | –4.7 | –9.0 |
| Consolidated balance sheet data: | |||
| Total equity | 34.2 | 41.8 | 26.1 |
| Equity ratio (in %) | 43.9% | 53.8% | 36.2% |
| Total assets | 78 | 77.7 | 72.2 |
| Consolidated cash flow data: | |||
| Cash flows from operating activities | –1.5 | –3.9 | –4.8 |
| Cash flows from investing activities | –12.7 | –2.2 | –4.5 |
| Cash flows from financing activities | –2.0 | 11.6 | –13.1 |